ArticleBritish journal of cancer2013

Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.

Y-C Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.